While the crypto community has been eagerly focused on the developments surrounding Genesis Trading and Digital Currenc Group (DCG) over the past few days, Ripple Labs continues to battle the U.S. Securities and Exchange Commission (SEC). And the next important deadlines are already looming.
By November 30, both Ripple and the SEC have to file their summary judgment briefs, which will remain under seal for the time being. On December 02, the two parties will meet to jointly discuss the redactions for the court filings.
A few days later, on December 05, Ripple’s and the SEC’s briefs will be made public. Finally, on December 22, the omnibus motions to seal all documents related to the summary judgment motions will be filed.






All while Pfizer—a company with a $2.3 billion criminal fine for fraudulent marketing, bribery, and kickbacks—was given blanket immunity from liability and billions in taxpayer dollars to produce a vaccine in record time with no long-term safety data.










